Akebia Therapeutics Inc [AKBA] stock Resumed by H.C. Wainwright analyst, price target now $8
Akebia Therapeutics Inc [NASDAQ: AKBA] gained 1.68% on the last trading session, reaching $5070000.0 price per share at the time. Akebia Therapeutics Inc represents 261.64 million in outstanding shares, while the company has a total market value of $953.37 million with the latest information. AKBA